Mesothelioma Cancer Centers
Helen F. Graham Cancer Center
Doctors Affiliated with this Treatment Facility
The Helen F. Graham Cancer Center is located on the Christiana Hospital Campus in Newark, Delaware, and is part of the Christiana Care Health System. The 200,000-square-foot facility serves the majority of cancer patients in Delaware. It is a designated community cancer center by the National Cancer Institute and specializes in advanced medical, surgical, radiation, and diagnostic services.
The cancer research program at the Helen F. Graham Cancer Center was selected to participate in the National Cancer Institute’s Community Clinical Oncology Program (CCOP). This allows the physicians and staff to utilize the most progressive cancer treatments. The facility collaborates with the University of Delaware to run the Center for Translational Research.
The multidisciplinary team of surgeons, medical oncologists, hematologists, and radiation oncologists are specialized in their fields and work together to deliver care based on each individual diagnosis. Specialists use diagnostic imaging such as Computer Tomography Scans (CT) and Magnetic Resonance Imaging (MRI) to determine the severity of the cancer and decide which therapy is necessary. Radiation treatments such as external beam radiation, image-guided, intensity-modulated radiation therapy, stereotactic radiosurgery, stereotactic radiotherapy, Total Body Irradiation (TBI), and brachytherapy are available as well.
The Christiana Care Health System is a modern, unified health system that is committed to improving the health of the community. The health system is made up of two main teaching hospitals and a variety of facilities located throughout northern Delaware and its surrounding areas. It has become one of the premier health care systems on the east coast.
The Christiana Hospital opened in January of 1985 and became the foundation for the Christiana Care Health System, providing most of the community’s health care. In 1995, two major expansion projects took place at the Christiana Hospital. An emergency and trauma center and women’s health wing were included to better serve the state. Years later, the health care system went on to develop the center for Heart and Vascular Health and the Helen F. Graham Cancer Center.
Mesothelioma Treatment at the Helen F. Graham Cancer Center
The Thoracic, Esophageal, and Lung Cancer Multidisciplinary Center at the Helen F. Graham Cancer Center is home to thoracic surgeons who utilize a multimodality treatment approach for patients with mesothelioma, lung cancer, esophageal cancer, and other malignancies of the chest. The cancer care management team provides extensive care and support for patients and their families.
Malignant mesothelioma is an uncommon cancer which makes it difficult to treat. It may occur as a cancerous tumor in the lining of the chest cavity, lung, or lining of the abdomen. The most effective way to treat mesothelioma and other thoracic and esophageal cancers is a combination of surgery, chemotherapy, and radiation. Surgeons, medical oncologists, and radiation oncologists join together as the multidisciplinary team at the Helen F. Graham Cancer Center. The expert thoracic surgeons use the most advanced technology and techniques available to manage malignant and non-malignant diseases including minimally invasive cancer staging and treatment, Radiofrequency Ablation of Lung Tumors (RALT), and Video-assisted thorascopic (VATS) lobectomies.
The section chief of thoracic surgery, Thomas Lee Bauer, M.D., joined the Christiana Care Health System in 2002. He is certified with the American Board of Surgery and American Board of Thoracic Surgery; part of the American College of Surgeons, American Society of Surgical Oncology, and College of Chest Physicians. Bauer has aimed to advance various treatments of lung and esophageal cancers. He has initiated and led a vast number of programs and research projects throughout Delaware, as well as nationwide. Bauer has worked with advanced 3D medical imaging, virtual bronchoscopy, and epidemiological studies of lung cancer.Sources